Stocks · Health care · Wholesale-Drugs, Proprietaries & Druggists' Sundries

Cencora

COR Clue Score59
United States Fiscal year ends September CIK 0001140859 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Lazarus Krikorian
2 Nov 2026
SVP & Chief Accounting Officer
Sold on a plan
986
$330.96
$326.33K
Lazarus Krikorian
1 Oct 2026
SVP & Chief Accounting Officer
Sold on a plan
986
$303.18
$298.94K
Lon R Greenberg
16 Sep 2026
Director
Sell
1,280
$321.30
$411.26K
Lazarus Krikorian
1 Sep 2026
SVP & Chief Accounting Officer
Sold on a plan
985
$325.97
$321.08K
Elizabeth S Campbell
24 Aug 2026
Executive Vice President
Sell
11,300
$324.12
$3.66M
Lauren M Tyler
22 Jun 2026
Director
Buy
550
$270.23
$148.63K
Dermot Mark Durcan
18 Jun 2026
Director
Buy
4,000
$274.19
$1.10M
Dermot Mark Durcan
28 May 2026
Director
Buy
4,000
$266.26
$1.07M
Robert P. Mauch
20 Feb 2026
President & CEO
Sold after exercise
3,762
$358.94
$1.35M
Robert P. Mauch
18 Feb 2026
President & CEO
Sold on a plan
1,333
$359.46
$479.16K
Robert P. Mauch
20 Jan 2026
President & CEO
Sold after exercise
5,096
$354.73
$1.81M
Elizabeth S Campbell
19 Dec 2025
Executive Vice President
Sell
3,351
$342.10
$1.15M
Silvana Battaglia
19 Dec 2025
Executive Vice President
Sell
1,677
$345.00
$578.57K
Robert P. Mauch
18 Dec 2025
President & CEO
Sold after exercise
5,096
$343.45
$1.75M
James F Cleary
17 Dec 2025
Chief Financial Officer
Exercised, kept
45,154
$86.09
$3.89M
Lazarus Krikorian
17 Dec 2025
SVP & Chief Accounting Officer
Sell
4,031
$343.24
$1.38M
Robert P. Mauch
18 Nov 2025
President & CEO
Sold after exercise
5,096
$366.64
$1.87M

What was left out

Form 4 filings counted 69
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 4
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 369,833
History held since 2 Nov 2006